Frontlight ResearchEarly access
Trial site
US Oncology Investigational Product Center (IPC)
- 10running trials
- 2closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Metastatic breast cancer4 trials
- Bladder cancer2 trials
- Cervical cancer2 trials
- Prostate cancer2 trials
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Liver and biliary tract cancer1 trial
- Ovarian cancer1 trial
- and 1 more
- Phase
- Phase 35 trials
- Phase 12 trials
- Phase 1/22 trials
- Phase 22 trials
- Phase 2/31 trial
- Status
- Recruiting6 trials
- Active, not recruiting4 trials
- Completed1 trial
- Terminated1 trial
- Lead sponsor
- Pfizer8 trials
- Seagen, a wholly owned subsidiary of Pfizer4 trials
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Active, not recruiting
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Active, not recruiting
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Bladder cancer2 recruiting
- Cervical cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026